More programs, more candles, more light.

Get the Flash Player to see this player.

Loading the player ...

Translational Oncology activity of Kyowa Kirin, Discovery and development of CCR4 monoclonal antibody, mogamulizumab

Yukimasa Shiotsu, PhD, Kyowa Hakko Kirin California Inc.

April 11, 2013
18 minutes
Yukimasa Shiotsu


Yukimasa Shiotsu, PhD, is Director of Translational Oncology for Kyowa Hakko Kirin California. He has more than 15 years experience in oncology research/development and has managed several research and development projects for Kyowa Hakko Kogyo Co. and Kyowa Hakko Kirin Co. (KHK). Shiotsu is a board member of Japanese Association of Metastasis Cancer Research and is a member of the Japanese Association for Cancer Research, the Japanese Association for Molecular Target Therapy of Cancer, the American Association of Cancer Research and the American Society of Hematology.